# Duke Resident Physician-Scientist Program- NIAID

> **NIH NIH R38** · DUKE UNIVERSITY · 2021 · $355,810

## Abstract

The physician-scientist workforce has been an important driver for many of the substantial discoveries in
infectious, immunologic, and allergic diseases over the last two decades. Yet, the pipeline of clinician-scientist
trainees has been in decline, fueled by complexity and requirements of clinical training, mounting debt after
medical school, declining NIH paylines, and importantly, lack of access to research mentorship during clinical
training. After four or more years of residency training with little time or support for research endeavors, there
are many hurdles for research-oriented trainees to initiate or re-initiate research. This represents a major gap
in the development of physician-scientists prepared to translate research into the clinical arena during their
careers. The primary goal of the multidisciplinary Duke Scientist-Clinician-Investigator Stimulating access to
Research during Residency (Duke SCI-StARR) program is to train physician-scientists in all aspects of
biomedical research in order to cultivate investigators who will lead the development, implementation, and
evaluation of new clinical modalities to diagnose, treat and prevent infectious, immunologic and allergic
diseases in children and adults. Duke SCI-StARR will train residents across 3 departments: Pediatrics,
Medicine, and Surgery in areas along the full biomedical research continuum (basic/translational, early
phase clinical trials and pharmacokinetics, and late phase clinical trials and outcomes) with a theme of
improving health over the life course. The program will consist of four training aims: 1) comprehensive
didactics covering basic, translational, and clinical research and professional development; 2) development
and completion of a research project and an individualized career development plan; 3) establishment of a
track record of scholarly activity; and 4) eligibility for board certification and continuation to subspecialty
training. Duke SCI-StARR will be led by an Executive Committee (EC) of MPIs Sallie Permar, MD, PhD
(Pediatrics), Scott Palmer, MD, MHS (Medicine), and David Harpole, Jr, MD (Surgery), and a SCI-StARR
Associate Program Director from each department, along with an Expanded EC of Residency Program
Directors and Program Coordinators, and will capitalize on a team of 22 multi-departmental, multi-disciplinary,
well-funded, and experienced faculty preceptors. This application requests support for three Resident-
Investigators each year with each trainee to be supported for 18-24 months of reseach. Upon completion of the
program, these individuals will be capable of transitioning to research-intense fellowship training, successfully
competing for extramural funding to support a path to independence, and becoming the next generation of
physicians leading and mentoring trainees in clinically-oriented research of allergy, immunology, and infectious
diseases affecting children and adults. Acheivement of the program's objectives will fulfill urgent...

## Key facts

- **NIH application ID:** 10219075
- **Project number:** 5R38AI140297-04
- **Recipient organization:** DUKE UNIVERSITY
- **Principal Investigator:** Rachel G Greenberg
- **Activity code:** R38 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $355,810
- **Award type:** 5
- **Project period:** 2018-08-01 → 2024-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10219075

## Citation

> US National Institutes of Health, RePORTER application 10219075, Duke Resident Physician-Scientist Program- NIAID (5R38AI140297-04). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10219075. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*